PharmaFluidics

Ghent, Belgium Founded: 2010 • Age: 16 yrs Acquired By Thermo Fisher Scientific
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
Request Access

About PharmaFluidics

PharmaFluidics is a company based in Ghent (Belgium) founded in 2010 was acquired by Thermo Fisher Scientific in November 2021.. The company has 14 employees as of December 31, 2021. PharmaFluidics operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.

  • Headquarter Ghent, Belgium
  • Employees 14 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pharmafluidics Nv
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of PharmaFluidics

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round
  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2018 Amount Series A - PharmaFluidics Valuation SFPI , PMV
Jan, 2017 Amount Series A - PharmaFluidics Valuation Qbic Fund , PMV
Jun, 2014 Amount Seed - PharmaFluidics Valuation Qbic Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PharmaFluidics

PharmaFluidics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, PMV and SFPIM. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity is directed toward private and public companies.
Founded Year Domain Location
Private debt funds are managed across multiple sectors.
Founded Year Domain Location
Venture capital fund investing in technological breakthroughs from universities.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PharmaFluidics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PharmaFluidics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pharmafluidics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PharmaFluidics

PharmaFluidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Continuous countercurrent tangential chromatography separation technology is developed.
domain founded_year HQ Location
Chromatography technologies for protein separation and biomolecule recovery are provided.
domain founded_year HQ Location
Solutions for chromatographic biomolecular separation are developed and provided.
domain founded_year HQ Location
Provider of proprietary filtration solutions for life science
domain founded_year HQ Location
Small molecule analysis and purification services are provided using chromatography.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pharmafluidics

Frequently Asked Questions about PharmaFluidics

When was PharmaFluidics founded?

PharmaFluidics was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is PharmaFluidics located?

PharmaFluidics is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.

How many employees does PharmaFluidics have?

As of Dec 31, 2021, the latest employee count at PharmaFluidics is 14.

What is the annual revenue of PharmaFluidics?

Annual revenue of PharmaFluidics is $842.5K as on Dec 31, 2019.

What does PharmaFluidics do?

PharmaFluidics was founded in 2010 in Ghent, Belgium, and operates within the life sciences sector focused on chromatography tools. Proprietary µPAC cartridges are provided as plug-and-play solutions for analyzing trace compounds in complex mixtures and detecting modifications in biological molecules. These cartridges, produced via lithographic micromachining, support biomarker research with controlled flow rates, enhanced resolution, and improved repeatability in standard nano-LC systems.

Who are the top competitors of PharmaFluidics?

PharmaFluidics's top competitors include ChromaTan, Sepragen and Sepax Technologies.

Who are PharmaFluidics's investors?

PharmaFluidics has 7 investors. Key investors include Thermo Fisher Scientific, PMV, SFPIM, Qbic Venture Partners, and Theodorus.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available